The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018

Amendment of regulation 3 of the PMS Agreements Regulations

20.—(1) Regulation 3 of the PMS Agreements Regulations(1) (interpretation) is amended as follows.

(2) In paragraph (b)(ii) of the definition of “prescription form”, for “nominated dispensing contractor” substitute “nominated dispenser or via an information hub”.

(3) In paragraph (b)(ii) of the definition of “repeatable prescription”, for “nominated dispensing contractor” substitute “nominated dispenser or via an information hub”.

(4) At the appropriate place in the alphabetical order insert—

““authorised person”, in relation to a patient, is a person who is entitled to make an application for pharmaceutical services on behalf of the patient by virtue of regulation 116(a) to (c) of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (authorised persons to apply for services);”.

(5) At the appropriate place in the alphabetical order insert—

““contractor’s EPS phase 4 date” means the date, encoded within the Electronic Prescription Service software, which is the date that a contractor has agreed is to be the date on and after which the contractor’s prescribers are to use the Electronic Prescription Service for all eligible prescriptions;”.

(6) At the appropriate place in the alphabetical order insert—

““EPS token” means a form (which may be an electronic form), approved by the Secretary of State, which—

(a)

is issued by a prescriber at the same time as an electronic prescription is created; and

(b)

has a barcode that enables the prescription to be dispensed by a provider of pharmaceutical services that is able to use the Electronic Prescription Service for the purposes of dispensing prescriptions, in circumstances where the provider is not dispensing the prescription as a nominated dispenser;”.

(1)

Regulation 3 has been amended by S.I. 2016/696 and 1077 and 2018/844.